|
OKANO Teruo
Department Research Institutes and Facilities, Research Institutes and Facilities Position |
|
| Article types | Review article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Trends in Articular Cartilage Tissue Engineering: 3D Mesenchymal Stem Cell Sheets as Candidates for Engineered Hyaline-Like Cartilage |
| Journal | Formal name：Cells. Abbreviation：Cells ISSN code：20734409 |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 10(3),pp.643 |
| Author and coauthor | THORP Hallie†, KIM Kyungsook*, KONDO Makoto, MAAK Travis, GRAINGER David W., OKANO Teruo* |
| Authorship | Last author,Corresponding author |
| Publication date | 2021/03/13 |
| Summary | Articular cartilage defects represent an inciting factor for future osteoarthritis (OA) and degenerative joint disease progression. Despite multiple clinically available therapies that succeed in providing short term pain reduction and restoration of limited mobility, current treatments do not reliably regenerate native hyaline cartilage or halt cartilage degeneration at these defect sites. Novel therapeutics aimed at addressing limitations of current clinical cartilage regeneration therapies increasingly focus on allogeneic cells, specifically mesenchymal stem cells (MSCs), as potent, banked, and available cell sources that express chondrogenic lineage commitment capabilities. Innovative tissue engineering approaches employing allogeneic MSCs aim to develop three-dimensional (3D), chondrogenically differentiated constructs for direct and immediate replacement of hyaline cartilage, improve local site tissue integration, and optimize treatment outcomes. Among emerging tissue engineering technologies, advancements in cell sheet tissue engineering offer promising capabilities for achieving both in vitro hyaline-like differentiation and effective transplantation, based on controlled 3D cellular interactions and retained cellular adhesion molecules. This review focuses on 3D MSC-based tissue engineering approaches for fabricating “ready-to-use” hyaline-like cartilage constructs for future rapid in vivo regenerative cartilage therapies. We highlight current approaches and future directions regarding development of MSC-derived cartilage therapies, emphasizing cell sheet tissue engineering, with specific focus on regulating 3D cellular interactions for controlled chondrogenic differentiation and post-differentiation transplantation capabilities. |
| DOI | 10.3390/cells10030643 |